Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This transcript (ENSG00000299957), annotated as "novel transcript, sense intronic to FARS2," is a non-coding RNA of unclear and unstudied function within the intronic region of the *FARS2* gene. There is no evidence it encodes a protein or is directly involved in any known biological process, disease, or drug mechanism. The canonical therapeutic target for this locus is the protein-coding gene *FARS2* (Phenylalanyl-tRNA synthetase 2, mitochondrial), which is associated with mitochondrial translation and several inherited diseases, but the transcript represented by ENSG00000299957 itself does not appear to have established scientific or clinical importance[1][2][3][4]. If your query intended to address *FARS2* rather than this non-coding transcript, substantial molecular, functional, and disease-related details are available for the *FARS2* protein (see sources for further information)[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to FARS2.